StockNews.com cut shares of CorVel (NASDAQ:CRVL – Free Report) from a buy rating to a hold rating in a research report released on Friday.
CorVel Trading Up 1.9 %
Shares of CorVel stock opened at $247.21 on Friday. CorVel has a 12-month low of $187.92 and a 12-month high of $265.14. The stock has a market cap of $4.23 billion, a PE ratio of 57.22 and a beta of 1.08. The company has a 50-day moving average of $243.15 and a two-hundred day moving average of $232.35.
Insider Activity at CorVel
In related news, CEO Michael G. Combs sold 301 shares of the stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $246.82, for a total value of $74,292.82. Following the sale, the chief executive officer now directly owns 21,082 shares of the company’s stock, valued at approximately $5,203,459.24. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, Chairman V Gordon Clemons sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $264.00, for a total value of $264,000.00. Following the completion of the sale, the chairman now directly owns 310,534 shares in the company, valued at $81,980,976. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Michael G. Combs sold 301 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $246.82, for a total transaction of $74,292.82. Following the completion of the sale, the chief executive officer now owns 21,082 shares of the company’s stock, valued at $5,203,459.24. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,543 shares of company stock valued at $2,881,792. Insiders own 48.71% of the company’s stock.
Institutional Investors Weigh In On CorVel
CorVel Company Profile
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Further Reading
- Five stocks we like better than CorVel
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 Value Stocks You Can Buy Before They Become Big
- EV Stocks and How to Profit from Them
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.